SCHEMBL6315675

SCHEMBL6315675

CCC(CCc1sc2c(c1C#N)CCC(=O)C2)CNC(=O)c1ccccc1O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPK10 P53779 6/20 0.34
MAPT P10636 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SAE1 Q9UBE0 1/20 0.34
UBA2 Q9UBT2 1/20 0.34
ALDH1A1 P00352 5/20 0.34
RAB9A P51151 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
TSHR P16473 2/20 0.33
MAPK9 P45984 1/20 0.33
GLA P06280 1/20 0.33
HTT P42858 1/20 0.33
HPGD P15428 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NAAA Q02083 1/20 0.32
LMNA P02545 2/20 0.32
KDM4E B2RXH2 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4043014 0.79 MAPK10 (0.35) NPC1MEN1KMT2AMAPK10ALDH1A1
SCHEMBL4042505 0.78 ALDH1A1 (0.40) NPC1MEN1KMT2AMAPTNPSR1
SCHEMBL4038702 0.78 MAPT (0.38) NPC1MEN1KMT2AMAPTNPSR1
SCHEMBL4042444 0.78 ALDH1A1 (0.39) NPC1MEN1KMT2AMAPTNPSR1
SCHEMBL4035984 0.78 MAPK10 (0.39) NPC1MEN1KMT2AMAPK10MAPT
SCHEMBL4045354 0.77 GCGR (0.40) NPC1MEN1KMT2AMAPK10MAPT
SCHEMBL4046896 0.77 GCGR (0.37) NPC1MEN1KMT2AMAPTNPSR1
SCHEMBL4040360 0.77 GCGR (0.49) NPC1MEN1KMT2AMAPTNPSR1
SCHEMBL4045769 0.77 TP53 (0.35) NPC1MEN1KMT2AMAPTNPSR1
SCHEMBL4043069 0.76 GCGR (0.43) NPC1MEN1KMT2AMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239865-A1 Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use MERCK SHARP & DOHME CORP. 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239865-A1 Substituted bicyclic thiophene derivatives, compositions containing such compounds and methods of use GLP1R, GCGR, GPR119 NPC1 1088/4885MEN1 3106/4885KMT2A 4315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.